Score Overview
Explore the 2021 public Archive ranking →
Where Anixa Biosciences Inc has ranked, year by year
Showing 5 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- ANIX
1996: 99.8% · 2021: 89.0% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 2.85 | — |
1 Year2025-09-29 | $ 3.41 | -16.42% |
5 Years2021-09-29 | $ 4.75 | -40.00% |
10 Years2016-09-29 | $ 3.27 | -12.84% |
20 Years2006-09-29 | $ 14.75 | -80.68% |
30 Years1996-09-27 | $ 181.25 | -98.43% |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | 30 Years1996-09-27 |
|---|---|---|---|---|---|---|
| Price | $ 2.85 | $ 3.41 | $ 4.75 | $ 3.27 | $ 14.75 | $ 181.25 |
| Return | — | -16.42% | -40.00% | -12.84% | -80.68% | -98.43% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 0.00 | -$ 7M | $ 13M |
| 2025 | $ 0.00 | -$ 10M | $ 15M |
| 2024 | $ 0.00 | -$ 12M | $ 19M |
| 2023 | $ 210K | -$ 9M | $ 23M |
| 2022 | -$ 13M | $ 29M | |
| 2021 | $ 512K | -$ 12M | $ 35M |
| 2020 | $ 0.00 | -$ 10M | $ 9M |
| 2019 | $ 250K | -$ 11M | $ 5M |
| 2018 | $ 1M | -$ 13M | $ 5M |
| 2017 | $ 362.5K | -$ 5M | $ 6M |
| 2016 | $ 300K | -$ 5M | $ 3M |
| 2015 | $ 9M | -$ 1M | $ 6M |
| 2014 | $ 3M | -$ 9M | $ 5M |
| 2013 | $ 388.85K | -$ 10M | $ 898.17K |
| 2012 | $ 940.01K | -$ 4M | $ 839.69K |
| 2011 | $ 1M | -$ 7M | $ 3M |
| 2010 | $ 730.67K | -$ 5M | $ 1M |
| 2009 | $ 1M | -$ 16M | $ 2M |
| 2008 | $ 2M | -$ 5M | $ 1M |
| 2007 | $ 486.85K | -$ 5M | $ 1M |
| 2006 | $ 508.65K | -$ 7M | $ 1M |
| 2005 | $ 439.79K | -$ 4M | $ 506.52K |
| 2004 | $ 494.46K | -$ 3M | $ 1M |
| 2003 | $ 244.22K | -$ 3M | $ 1M |
| 2002 | $ 5M | -$ 3M | $ 854.82K |
| 2001 | $ 1M | -$ 3M | $ 1M |
| 2000 | $ 1M | -$ 4M | $ 1M |
| 1999 | $ 100K | -$ 8M | $ 2M |
| 1998 | $ 100K | -$ 7M | $ 5M |
| 1997 | $ 100K | -$ 5M | $ 12M |
| 1996 | $ 100K | -$ 5M | $ 22M |
| 1995 | $ 100K | -$ 3M | $ 8M |
| 1994 | $ 100K | -$ 3M | $ 6M |
| 1993 | $ 100K | -$ 2M | $ 8M |
| 1992 | $ 100K | -$ 1M | $ 4M |
| 1991 | $ 100K | -$ 1M | $ 4M |
| 1990 | $ 100K | -$ 1M | $ 2M |
| 1989 | $ 100K | -$ 1M | $ 2M |
| 1988 | $ 100K | -$ 1M | $ 1M |
| IPO1987 | $ 100K | -$ 1M | $ 700K |
Anixa Biosciences Inc fundamental performance
Between 2020 and 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 10M to -$ 10M. Revenue increased in 0 of those 5 years; net income in 3.
Between 2015 and 2025, revenue declined from $ 9M to $ 0.00 and net income went from -$ 1M to -$ 10M. Revenue increased in 4 of those 10 years; net income in 6.
Anixa Biosciences Inc currently holds a 20-year HDB Score of 2.5 out of 10. How the HDB Score is calculated.
Membership
Continue ANIX’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
